May 09, 2017 11:02 am UTC| Business
ALAMEDA, Calif., May 09, 2017 -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive tests for the early detection of cancer,announced today that William Haack, Vice President of Market Access, will...
May 09, 2017 11:02 am UTC| Business
ADVISORY, May 09, 2017 -- WHO:Emergent BioSolutions Inc.(NYSE:EBS)WHAT:Ribbon-cutting and tour of expanded Emergent BioSolutions’ Center forInnovation in Advancement Development and Manufacturing (CIADM),featuring...
May 09, 2017 11:02 am UTC| Business
ADVISORY, May 09, 2017 -- WHO:Emergent BioSolutions Inc.(NYSE:EBS)WHAT:Ribbon-cutting and tour of expanded Emergent BioSolutions’ Center forInnovation in Advancement Development and Manufacturing (CIADM),featuring...
May 09, 2017 11:02 am UTC| Business
ADVISORY, May 09, 2017 -- WHO:Emergent BioSolutions Inc.(NYSE:EBS)WHAT:Ribbon-cutting and tour of expanded Emergent BioSolutions’ Center forInnovation in Advancement Development and Manufacturing (CIADM),featuring...
Axsome Therapeutics Reports First Quarter 2017 Financial Results
May 09, 2017 11:02 am UTC| Business
NEW YORK, May 09, 2017 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today reported...
Axsome Therapeutics Reports First Quarter 2017 Financial Results
May 09, 2017 11:02 am UTC| Business
NEW YORK, May 09, 2017 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today reported...
Axsome Therapeutics Reports First Quarter 2017 Financial Results
May 09, 2017 11:02 am UTC| Business
NEW YORK, May 09, 2017 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today reported...
Threading Opportunity: How an India–EU FTA Could Reweave Textile Fortunes